GSTM1 and anemia: Dasatinib-treated Vps13a−/− mice developed mild anemia associated with a significant reduction in reticulocyte count (Hb vehicle: 14.6 ± 0.8 vs. Hb dasatinib: 10.3 ± 1.5 g/dL; n = 8; p < 0.02; retic vehicle 390 ± 62 cell/μL vs. retic dasatinib: 201 ± 84 cell/μL n = 6; p < 0.05).